Domestic alternative breaks international monopoly, holds global compliance certifications
Guangzhou, China – 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical lipid excipients in China, emerges as a core domestic supplier of high-purity egg yolk lecithin, addressing critical supply chain pain points for global pharmaceutical enterprises. The company’s breakthrough technology has broken long-term international monopoly, boosting domestic localization rate from 10% to 90%, and its products have obtained multiple global certifications, selling to over 30 countries and regions worldwide.
Core Technological Breakthroughs & Product Highlights
Guangzhou Hanfang’s high-purity egg yolk lecithin is developed with an integrated green technology combining supercritical CO₂ extraction, membrane separation and chromatographic separation, replacing traditional polluting processes and establishing core technical barriers. As a pharmaceutical excipient, emulsifier and liposome membrane material, it provides stable domestic supply for pharmaceutical enterprises producing injectable emulsions, liposomes and other high-end preparations, solving the long-term reliance on imported raw materials.
Global Compliance & Certifications
The product has obtained international certifications including EU CEP, US FDA US-DMF, Mexico Cofepris and India DCGI, meeting regulatory requirements of major global markets. Backed by top-tier research platforms such as the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation (the only national-level engineering research center in the pharmaceutical lipid field) and Guangdong Provincial Key Laboratory of Pharmaceutical Lipids, the company also holds national qualifications like National High-Tech Enterprise and National Specialized, Sophisticated, Unique and New "Little Giant" Enterprise.
Supply Information & Customized Services
High-purity egg yolk lecithin is available for global pre-order through authorized distributors and the official website, with mass production and global delivery ongoing. In addition to standard products, the company offers customized processing services for pharmaceutical enterprises, tailoring solutions to meet diverse formulation needs.
Authoritative Quotes
"Our high-purity egg yolk lecithin technology breaks international monopolies, ensuring the security of China’s pharmaceutical supply chain and providing reliable domestic alternatives for global clients," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited. "This achievement reflects our commitment to technological self-reliance and innovation, addressing 'bottleneck' issues in high-end pharmaceutical excipients."
Industry Background & Corporate Strategy
The global market for high-end pharmaceutical lipid excipients is growing rapidly, with traditional supply chains heavily reliant on imports, creating urgent demand for localized alternatives. Guangzhou Hanfang’s strategic layout in this field aligns with industry trends, positioning the company as a key player in global supply chain diversification.
Future Plans & Next Steps
Looking ahead, Guangzhou Hanfang will continue to deepen its focus on high-end pharmaceutical lipid excipients, increase R&D investment, and launch more innovative products to meet global market demands. The company targets double-digit growth in revenue and profit in 2026, accelerating its international expansion.
Company Profile
Established in 1998, Guangzhou Hanfang Pharmaceutical Company Limited is a wholly state-owned subsidiary of Guangzhou Pharmaceutical Holdings, specializing in active pharmaceutical ingredients, pharmaceutical lipid excipients, health products and technical services. With over 240 patents, the company serves more than 1,000 clients including B. Braun Company and AstraZeneca, and its products are sold in over 20 countries and regions. Its mission is to achieve technological self-reliance, solve "bottleneck" problems, and safeguard pharmaceutical supply chain security. For more information, visit http://byshanhanfang.com/.
Contact Information
Company: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/
© 2026 Guangzhou Hanfang Pharmaceutical Company Limited. All rights reserved.
